BioSpace News Archive

Press Releases

EISAI PRESENTS LATEST CLINICAL FINDINGS SUGGESTING INHIBITION OF TAU PROPAGATION BY ANTI-MTBR TAU ANTIBODY E2814 AT THE 17TH CLINICAL TRIALS ON ALZHEIMER’S DISEASE CONFERENCE (CTAD)

October 31, 2024
·
4 min read
Press Releases

Kelun-Biotech’s TROP2-ADC SKB264 (sac-TMT) Third NDA Accepted by NMPA, locally advanced or metastatic EGFR-mutant NSCLC

October 31, 2024
·
4 min read
Press Releases

Ultimovacs ASA: Invitation to third quarter 2024 results webcast presentation

October 31, 2024
·
1 min read
Press Releases

Roche presents new data at CTAD, demonstrating its growing momentum in diagnostics for Alzheimer’s disease

October 31, 2024
·
8 min read
Press Releases

Vistin Pharma ASA: Third quarter and YTD 2024 financial results

October 31, 2024
·
1 min read
Press Releases

New England Journal of Medicine publishes landmark phase III results for Roche’s Itovebi, showing more than doubling of progression-free survival in certain type of HR-positive advanced breast cancer

October 31, 2024
·
10 min read
Press Releases

argenx Reports Third Quarter 2024 Financial Results and Provides Business Update

October 31, 2024
·
15 min read
Press Releases

Kyowa Kirin Announces Changes in Top Leadership Positions to Strengthen Operations as a Global Specialty Pharmaceutical Company

October 31, 2024
·
3 min read
Press Releases

NANOBIOTIX to Participate in Multiple Investor Conferences in November 2024

October 31, 2024
·
2 min read
Press Releases

Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024

October 31, 2024
·
1 min read